InvestorsHub Logo
Followers 116
Posts 18515
Boards Moderated 0
Alias Born 08/27/2005

Re: NASDAQ2020 post# 202466

Monday, 05/30/2016 12:14:24 PM

Monday, May 30, 2016 12:14:24 PM

Post# of 400025
With the FDA its always an if. The things they should do and the things they do do often leave one scratching their head.

Like the most recent LA Times article where there are even some physicians that agree that the 12 hour formulation OxyContin does not give a full relief of pain for 12 hours. This was even proven in BE testing of this formulation. Yet the FDA granted Purdue the labeling for 12 hour relief. The labeling should be changed as the article points out... but will the FDA have Purdue change the labeling?

NASDAQ what the FDA should do is mandate a time period for these companies to either have an ADF in place or be subject to having their non ADF version pulled from the market. Simple as that.
Once SequestOx and other Elite ADF versions of opioids are out there then the FDA can act on something along these lines?

It is amazing how fast the bear can move once you put a fire to his hind quarters.

It can be done... it should be done... but will the FDA do it in a timely fashion?

For now SequestOx is the main target. Maybe June 8th another will also materialize.

My hope is that

Not "if" but "when" the FDA removes non- abuse deterrent opiods.

happens sooner than later.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News